At a glance
ClinicalIndex Comparison RecordN/ACompleted· 252 enrolled
Drug / intervention
Risk and Protective Factors Assessmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicentre Prospective Cohort Study Assessing Risk and Protective Factors to Develop Psychopathology in Transitional Age Youth
In Brief
A clinical study evaluating Risk and Protective Factors Assessment for Transitional Care and 2 related conditions. Completed, enrolled 252 participants across 4 sites.
Detailed Summary
This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartJun 2020
Primary CompletionDec 2023
TodayJul 2026
First PostedApr 3, 2020
Enrollment StartJun 10, 2020
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.2 years ago
Interventions
Risk and Protective Factors Assessmentother
First assessment at baseline (T0) - 17 y.o. Follow-up 2 years later (T1) - 19 y.o.